CQS Cayman’s Merck MRK Stock Holding History

CQS Cayman’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-52,400	Closed	-$2.84M	–	232
2014 Q4	$2.84M	Buy	+52,400	New	+$2.92M	0.19%	93

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CQS Cayman's MRK Position: Q1 2015 in Review

CQS Cayman sold out of Merck (MRK) in Q1 2015, closing a stake of 52,400 shares — an estimated $2.84M sold.

CQS Cayman first reported a position in MRK in Q4 2014 and held it in 1 quarter. The position peaked at $2.84M in Q4 2014. 1,711 funds tracked by Wall St. Rank hold MRK as of Q1 2015.

CQS Cayman reported no remaining Merck position as of Q1 2015 after selling out during the quarter.
CQS Cayman sold 52,400 Merck shares in Q1 2015, an estimated $2.84M.
CQS Cayman first reported a position in Merck in Q4 2014 and held it in 1 quarter.
CQS Cayman's Merck position peaked at $2.84M in Q4 2014.
1,711 funds tracked by Wall St. Rank held Merck as of Q1 2015.

Based on CQS Cayman's 13F filing for Q1 2015, filed 13 May 2015.